Do GLP-1 Medicines Actually Cause Muscle Loss? New Research With Dr. Henning Langer
About this episode
The episode discusses the effects of GLP-1 medicines on muscle loss with insights from Dr. Henning Langer's research.
Dr. Spencer Nadolsky and Karl sit down with Dr. Henning Langer, a PhD researcher at the Charité in Berlin, to break down his newly published paper combining rodent and human data to look directly at what GLP-1 medicines actually do to skeletal muscle beyond what a DEXA scan can tell you. From mice running to exhaustion on semaglutide to maximum voluntary contraction data in humans, this is the most granular conversation yet on whether these drugs are doing something to muscle that nobody fully understands yet.
People in this episode
Hosts: Dr. Spencer Nadolsky, Karl
Guest: Dr. Henning Langer
Topics covered
- GLP-1 medicines
- muscle loss
- skeletal muscle
- human data
- rodent data
- exercise
- research
Keywords
- GLP-1
- muscle loss
- semaglutide
- skeletal muscle
- DEXA scan
- human data
- rodent data
- exercise
Mentioned in this episode
Organizations: Charité
Products: GLP-1 medicines, semaglutide
More episodes of Docs Who Lift
- GLP-1 Genetics: Predicting Weight Loss and Side Effects With 23andMe's Dr. Adam Auton
- How Often Should You Really Lift Weights? Feat. Dr. Stuart Phillips
- Bimagrumab and Semaglutide: The BELIEVE Trial Results With Dr. Steven Heymsfield
- Menopause, Muscle, and the Myths | Dr. Alyssa Olenick
- The Truth About Creatine (Doctors Discuss)
- Top Sleep Doctor: Stop Taking Melatonin Like This
Explore listener stats, chart rankings, contacts and more on the Docs Who Lift podcast page.